We found that the median and quartile of the mean 24-hour urinary protein excretion from 0 to 3 months after diagnosis decreased compared with the 24-hour urinary protein excretion at diagnosis in patients with anti-GBM disease combined with IgA deposition in the mesangial region. This evidence concerns the gene CD79A and glioblastoma.